DOXYCYCLINE HYCLATE tablet

Země: Spojené státy

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktivní složka:

DOXYCYCLINE HYCLATE (UNII: 19XTS3T51U) (DOXYCYCLINE ANHYDROUS - UNII:334895S862)

Dostupné s:

PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS

INN (Mezinárodní Name):

DOXYCYCLINE HYCLATE

Složení:

DOXYCYCLINE ANHYDROUS 100 mg

Podání:

ORAL

Druh předpisu:

PRESCRIPTION DRUG

Terapeutické indikace:

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Přehled produktů:

Doxycycline hyclate tablets, USP equivalent to 50 mg of doxycycline: Light beige color, round convex, film-coated tablets debossed "311" below, "B" on one side and plain on the other. Bottle of 60 tablets NDC 24658-311-60 Doxycycline hyclate tablets, USP equivalent to 100 mg of doxycycline: Beige color, round convex, film coated tablets debossed “312” below, “B” on one side and plain on the other. Bottles of 20 tablets NDC 24658-312-20 Bottles of 50 tablets NDC 24658-312-50 Bottles of 100 tablets NDC 24658-312-01 Bottles of 500 tablets NDC 24658-312-05 Bottles of 1000 tablets NDC 24658-312-10 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.

Stav Autorizace:

Abbreviated New Drug Application

Charakteristika produktu

DOXYCYCLINE HYCLATE- DOXYCYCLINE HYCLATE TABLET
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
----------
DOXYCYCLINE HYCLATE TABLETS, USP
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of
doxycycline hyclate tablets and other antibacterial drugs, doxycycline
hyclate tablets
should be used only to treat or prevent infections that are proven or
strongly suspected
to be caused by bacteria.
DESCRIPTION
Doxycycline is an antibacterial drug synthetically derived from
oxytetracycline, and is
available as doxycycline hyclate tablets for oral administration. The
chemical designation
of doxycycline is
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-
pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene-carboxamide
monohydrochloride,
compound with ethyl alcohol (2:1), monohydrate.
The structural formula of doxycycline hyclate is:
with a molecular formula of (C
H
N O •HCl) •C H O•H O and the molecular weight is
1025.89. Doxycycline is a light-yellow crystalline powder. Doxycycline
hyclate is soluble
in water.
Doxycycline has a high degree of lipoid solubility and a low affinity
for calcium binding. It
is highly stable in normal human serum. Doxycycline will not degrade
into an epianhydro
form.
Active Ingredient: Doxycycline hyclate USP equivalent to 50 mg or 100
mg of
doxycycline.
Inactive Ingredient: Microcrystalline cellulose and magnesium
stearate.
Tablet coating contains hypromellose, titanium dioxide, polyethylene
glycol, FD&C yellow
#6, polysorbate 80 and FD&C blue #2.
CLINICAL PHARMACOLOGY
Tetracyclines are readily absorbed and are bound to plasma proteins in
varying degree.
They are concentrated by the liver in the bile, and excreted in the
urine and feces at high
22
24
2
8
2
2
6
2
concentrations and in a biologically active form. Doxycycline is
virtually completely
absorbed after oral administration.
Following a 200 mg dose, normal adult volunteers averaged peak serum
levels of 2.6
mcg/mL of doxycycline at 2 hours, decreasing to 1.45 mcg/mL at 24
hours. Excretion